Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE007131 |
XU_ID: | XU-525 |
ID: | TCMBANKHE007131/XU-525 |
植物拉丁名: |
|
功能与主治: | To nourish blood and stanch bleeding, astringe intestines and secure essence./Blood vacuity and general weakness, blood ejection, nosebleed(epistaxis), taxation damage hemoptysis, hematochezia, flooding and spotting, emission, vaginal discharge, dysentery, prolapse of rectum, scalds, bleeding due to external injury. |
药用植物名: | 桃金娘 |
来源: | 广西省北海市银海区福成镇 |
药用部位: | fruit|枝叶 |
KUMST_ID1: | KMUST-BS-0538 |
KUMST_ID2: | KMUST-2024041100077-1 |
TCM_ID_id: | 4945 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000981 | trans-triacontyl-4-hydroxy-cinnamate | ||||
| TCMBANKIN001211 | piceatannol-4,-O-β-D-glucopyranoside | ||||
| TCMBANKIN001862 | 4-o-β-d-(6-o-vanilloyl glucopyranosyl)vanillicacid | C22H24O12 | |||
| TCMBANKIN002111 | myricetin-3一O-α-L-furanoarabinoside | ||||
| TCMBANKIN005711 | 4'-Hydroxy-3'-methoxycinnamaldehyde | (Z)-3-(4-hydroxy-3-methoxy-phenyl)acrolein; 2-Propenal, 3-(4-hydroxy-3-methoxyphenyl), (Z)-; EINECS 207-278-4; (Z)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal; (Z)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enal | C10H10O3 | 178.18 | COC1=C(C=CC(=C1)C=CC=O)O |
| TCMBANKIN007896 | rhodomyrtosone D | ||||
| TCMBANKIN010961 | Laricitrin | laricitrin; 2-(3,4-dihydroxy-5-methoxyphenyl)-3,5,7-trihydroxy-4-chromenone; 2-(3,4-dihydroxy-5-methoxy-phenyl)-3,5,7-trihydroxy-chromone; 2-(3,4-dihydroxy-5-methoxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; 53472-37-0; C12633; 2-(3,4-dihydroxy-5-methoxyphenyl)-3,5,7-trihydroxychromen-4-one; 3'-O-Methylmyricetin | C16H12O8 | 332.26 | COC1=CC(=CC(=C1O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O |
| TCMBANKIN011189 | rhodomyrtosone I | ||||
| TCMBANKIN012216 | 4, 8,9,10-tetrahydroxy-2,3,7-trimethoxyanthracene-6- O-β-D-glucopyranoside | ||||
| TCMBANKIN012705 | endoperoxide G3 | C14H20O5 | CC1(C=C2C(=O)C(C(=O)C(C2(OO1)O)(C)C)(C)C)C | ||
| TCMBANKIN012776 | kaempferol一3一0一α-L-furanoarabinoside | ||||
| TCMBANKIN013873 | malvidin-3一O-glucoside | ||||
| TCMBANKIN013936 | mymcetm | ||||
| TCMBANKIN014073 | 2,4,7,8,9,10-hexahydroxy-3-methoxyanthracene-6-O-α-L-rhamnopyranoside | ||||
| TCMBANKIN016405 | 3,3',4-tri-O-methylellagic acid | 3,3', 4-tri-o-methylellagic acid; 3,3',4-tri-o-methylellagic acid; 3,3',4-tri-o-methyl ellagicacid; 3,3',4-tri-o-methyl ellagic acid | 346.31 | ||
| TCMBANKIN016958 | Anthocyanins-3- galactosidase | ||||
| TCMBANKIN017237 | 3β-acetoxy-l2-oxo-oleanan-28,13β-olide | ||||
| TCMBANKIN017674 | Delphinidin-3-galactoside | C21H21ClO12 | 500.8 g/mol | C1=C(C=C(C(=C1O)O)O)C2=[O+]C3=CC(=CC(=C3C=C2OC4C(C(C(C(O4)CO)O)O)O)O)O.[Cl-] | |
| TCMBANKIN019499 | 3一O-(E)-coumaroyloleanolic acid | ||||
| TCMBANKIN019662 | 3α-acetoxy-25-hydroxyolean-12-en-28-oicacid | C32H50O5 | |||
| TCMBANKIN020142 | myricetin-3一O-α-L-rhamnoside | ||||
| TCMBANKIN020513 | Pelargonidin-3,5-glucoside | ||||
| TCMBANKIN021204 | myricetin-3一o-β-D-glucoside | ||||
| TCMBANKIN021480 | rhodomyrtosone C | C41H54O8 | 674.9 g/mol | CC(C)CC1C2=C(C(=C3C(=C2OC4=C1C(=O)C(C(=O)C4(C)C)(C)C)C(C5=C(O3)C(C(=O)C(C5=O)(C)C)(C)C)CC(C)C)C(=O)CC(C)C)O | |
| TCMBANKIN023818 | tomentosones B | C41H52O9 | CC(C)CC1C2=C(C(=C3C(=C2OC4=C1C(=O)C(C(=O)C4(C)C)(C)C)C5C6=C(C(C(=O)C(C6=O)(C)C)(C)C)OC5(O3)C(C)C)C(=O)CC(C)C)O | ||
| TCMBANKIN024331 | rhodomyrtone | C26H34O6 | 442.5 g/mol | CC(C)CC1C2=C(C=C(C(=C2O)C(=O)CC(C)C)O)OC3=C1C(=O)C(C(=O)C3(C)C)(C)C | |
| TCMBANKIN024829 | kaempferol-3一O-β-sambubioside | ||||
| TCMBANKIN025309 | (一)一(2R,3R)一1,4-O-diferuloylsecoisolariciresinol | C40H42O12 | COC1=C(C=CC(=C1)CC(COC(=O)C=CC2=CC(=C(C=C2)O)OC)C(CC3=CC(=C(C=C3)O)OC)COC(=O)C=CC4=CC(=C(C=C4)O)OC)O | ||
| TCMBANKIN025341 | petunidin-3一O-glucoside | ||||
| TCMBANKIN025783 | peonidin-3一O-glucoside | ||||
| TCMBANKIN025791 | cyanidin-3一O-glucoside | ||||
| TCMBANKIN025801 | α-amyrim | ||||
| TCMBANKIN027890 | 3一O-methylellagic acid | ||||
| TCMBANKIN028003 | delphinidin-3一O-glucoside | ||||
| TCMBANKIN030917 | 21α-hop-22(29)en-3β,30-diol | C30H50O2 | CC1(C2CCC3(C(C2(CCC1O)C)CCC4C3(CCC5C4(CCC5C(=C)CO)C)C)C)C | ||
| TCMBANKIN032531 | Tomentosin | NCGC00168921-01; ACon1_000603; 7-Methyl-3-methylene-6-(3-oxobutyl)-3,3a,4,7,8,8a-hexahydro-2H-cyclohepta[b]furan-2-one #; SCHEMBL10028477; CHEMBL483219; 2H-Cyclohepta[b]furan-2-one, 3,3a,4,7,8,8a-hexahydro-7-methyl-3-methylene-6-(3-oxobutyl)-, [3aR-(3a.alpha.,7.beta.,8a.alpha.)]-; AVFIYMSJDDGDBQ-UHFFFAOYSA-N; NCGC00168921-02!7-methyl-3-methylidene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3aH-cyclohepta[b]furan-2-one; (3aR,7S,8aR)-7-methyl-3-methylene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3aH-cyclohepta[d]furan-2-one; MCULE-9975535341; MEGxp0_000589; (3aR,7S,8aR)-6-(3-ketobutyl)-7-methyl-3-methylene-4,7,8,8a-tetrahydro-3aH-cyclohepta[d]furan-2-one; 68736-88-9; Parthenium; tomentosin; 33649-15-9; MolPort-001-740-745; 2H-Cyclohepta[b]furan-2-one, 3,3a,4,7,8,8a-hexahydro-7-methyl-3-methylene-6-(3-oxobutyl)-; 7-METHYL-3-METHYLIDENE-6-(3-OXOBUTYL)-3AH,4H,7H,8H,8AH-CYCLOHEPTA[B]FURAN-2-ONE; AC1LBQ61; (3aR,7S,8aR)-7-methyl-3-methylidene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3aH-cyclohepta[d]furan-2-one; 7-methyl-3-methylidene-6-(3-oxobutyl)-4,7,8,8a-tetrahydro-3aH-cyclohepta[b]furan-2-one; 2H-Cyclohepta(b)furan-2-one, 3,3a,4,7,8,8a-hexahydro-7-methyl-3-methylene-6-(3-oxobutyl)-, (3aR,7S,8aR)-; C09562; NP-001623 | C15H20O3 | 248.32 | CC1CC2C(CC=C1CCC(=O)C)C(=C)C(=O)O2 |
| TCMBANKIN033133 | gallic acid、3,3',4,4'-tetra-O-methylflavellagic acid | ||||
| TCMBANKIN033261 | rhodomyrtosone B | C26H34O6 | 442.5 g/mol | CC(C)CC1C2=C(C(=C(C=C2O)O)C(=O)CC(C)C)OC3=C1C(=O)C(C(=O)C3(C)C)(C)C | |
| TCMBANKIN033329 | 3β一acetoxy-l2α-hydroxyoleanan-28,13β-olide | ||||
| TCMBANKIN034555 | tomentosones A | ||||
| TCMBANKIN034897 | aliphitolic acid | ||||
| TCMBANKIN036013 | rhodomyrtosone A | C25H30O7 | 442.5 g/mol | CCCC(=O)C1=C(C=C(C2=C1OC3(C2C4=C(O3)C(C(=O)C(C4=O)(C)C)(C)C)C(C)C)O)O | |
| TCMBANKIN036233 | Toonacilin | toonacilin; AC1O3E5R; methyl 2-[(1R,2S)-2-[(1aR,3S,3aR,5S,6R,7aS)-4,5-diacetyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-6-yl]-2,6,6-trimethyl-5-oxocyclohex-3-en-1-yl]acetate | C31H38O9 | 554.63 | CC(=O)OC1C(C(=C)C23C(O2)CC(C3(C1OC(=O)C)C)C4=COC=C4)C5(C=CC(=O)C(C5CC(=O)OC)(C)C)C |
| TCMBANKIN036814 | β-Amyrin | SCHEMBL14226156; beta-Amyrine; β- amyrin; beta-amyrin ; beta-amyrin; 12-oleanex-3beta-ol; NSC-527971 | 426.72 | ||
| TCMBANKIN036829 | ursolic acid | ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 | C30H48O3 | 456.7 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-] |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN042698 | Arjunolic acid | Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2.alpha.,3.beta.,4.alpha.)-; arjunolic acid; arjunolicacid; 2,3,23-Trihydroxyolean-12-en-28-oic acid; AIDS046611; 465-00-9; (4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-9-methylol-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3beta,4alpha)-; AIDS-046611; (4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | C30H48O5 | 488.7 | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1)C)C(=O)O)C |
| TCMBANKIN043888 | pedunculagin | beta-Pedunculagin; 118014-30-5; VA85X55GDI; beta-D-Glucopyranose, cyclic 2,3:4,6-bis((1S)-4,4',5,5',6,6'-hexahydroxy(1,1'-biphenyl)-2,2'-dicarboxylate); 4-O,6-O-[(4,4',5,5',6,6'-Hexahydroxy-1,1'-biphenyl-2,2'-diyl)biscarbonyl]-2-O,3-O-[(4,4',5,5',6,6'-hexahydroxy-1,1'-biphenyl-2,2'-diyl)biscarbonyl]-beta-D-glucopyranose; UNII-VA85X55GDI | C34H24O22 | 785 | c1(O[H])c([H])c(C(OC([H])([H])[C@@]([H])(O[C@@]([H])(O[H])[C@]([H])(OC(=O)c2c(c3c(C(=O)O4)c([H])c(O[H])c(O[H])c3O[H])c(O[H])c(O[H])c(O[H])c2[H])[C@@]45[H])[C@@]5([H])OC(=O)c(c([H])c(O[H])c(O[H])c6O[H] )c67)=O)c7c(O[H])c1O[H] |
| TCMBANKIN047621 | casuariin | BDBM50269546; D0I1UF; CHEMBL509562; SCHEMBL1883046; casuariin ; Casuariin | C35H26O21 | 783 | c1(O[H])c(c([H])c2c(c3c(C(=O)O[C@]([H])([C@]([H])(C([H])([H])OC2=O)O[H])[C@]4([H])C([H])([H])C(=O)c5c(c6c(C(=O)O[C@@]47[H])c(c(O[H])c(O[H])c6O[H])[C@]7(O[H])[H])c(O[H])c(O[H])c(O[H])c5[H])c([H])c(O[H] )c(O[H])c3O[H])c1O[H])O[H] |
| TCMBANKIN049175 | casuarinin | SCHEMBL868365; Casuarinin; casuarinin ; CHEMBL507387; BDBM50250998 | C41H28O26 | 936.65 | C1C(C(OC(=O)C2=CC(=C(C(=C2C3=C(C(=C(C=C3C(=O)O1)O)O)O)O)O)O)C4C5C(C6=C(C(=C(C(=C6C(=O)O5)C7=C(C(=C(C=C7C(=O)O4)O)O)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)O)O)O |
| TCMBANKIN058100 | 2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose | 2,3-hexahydroxydiphenyl-D-glucose | C20H18O14 | 482.3 g/mol | C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O |
| TCMBANKIN058122 | piceatannol | (e)-piceatannol; NCGC00015794-01; 5-[(Z)-2-(3,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 5-[(Z)-2-(3,4-dihydroxyphenyl)vinyl]benzene-1,3-diol; Lopac-P-0453; PIT; e-piceatannol; (e)-piceatannol; 5-[(Z)-2-(3,4-dihydroxyphenyl)vinyl]resorcinol; NCGC00094226-05; 5-[(E)-2-(3,4-dihydroxyphenyl)vinyl]resorcinol; KBio3_000859; IDI1_002155; 3,3',4,5'-Tetrahydroxystilbene; 3,3',4,5'-Stilbenetetrol; C05901; EU-0100915; NSC 622471; 1,2-Benzenediol, 4-[2-(3,5-dihydroxyphenyl)ethenyl]-, (E)-; 3,3',4'5-Tetrahydroxystilbene; 5-[2-(3,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol; NSC365798; Lopac0_000915; 5-[2-(3,4-dihydroxyphenyl)vinyl]benzene-1,3-diol; 5-[2-(3,4-dihydroxyphenyl)vinyl]resorcinol; MEGxp0_000245; KBio2_000460; SMP2_000263; trans-3,3′,4,5′-Tetrahydroxystilbene; 1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-; 21100-92-5; trans-3,3',4,5'-Tetrahydroxystilbene; 5-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]benzene-1,3-diol; AIDS-160223; (E)-4-[2-(3,5Dihydroxyphenyl)ethenyl]1,2-benzenediol; Piceatannol; NSC 365798; 4339-71-3; E-Piceatannol; 3-Hydroxyresveratol; 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol; KBio2_005596; 10083-24-6; NCGC00094226-04; BiomolKI2_000031; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol; KBioGR_000460; Bio2_000880; KBioSS_000460; NSC622471; KBio2_003028; 5-[(E)-2-(3,4-dihydroxyphenyl)vinyl]benzene-1,3-diol; KBio3_000860; 3,5,3',4'-Tetrahydroxystilbene; 1,2-Benzenediol, {4-[2-(3,} 5-dihydroxyphenyl)ethenyl]-, (E)-; BSPBio_001120; NCGC00094226-02; NCI60_003368; 1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)-; Astringinine; P0453_SIGMA; BiomolKI_000023; AIDS160223; CHEBI:28814; 4-(2-(3,5-Dihydroxyphenyl)vinyl)-1,2-benzenediol; Bio2_000400; 3,3′,4,5′-Tetrahydroxy-trans-stilbene; K00089; ZINC00014036 | C14H12O4 | 244.24 g/mol | C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O |
| TCMBANKIN058565 | vescalagin | vescalagin;castalagin;castalagin | C41H26O26 | 934.6 g/mol | C1C2C(C3C4C(C5=C(C(=C(C(=C5C(=O)O4)C6=C(C(=C(C(=C6C(=O)O3)C7=C(C(=C(C=C7C(=O)O2)O)O)O)O)O)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)O |
| TCMBANKIN058703 | Betulonic acid | Lup-20(29)-en-28-oic acid, 3-oxo-; betulonicacid; 3-Deoxy-3-oxo-betulinic acid; 4481-62-3; betulonic acid; (1R,3aS,5aR,5bR,7aR,11aR,11bR,13aR,13bR)-1-Isopropenyl-5a,5b,8,8,11a-pentamethyl-9-oxo-eicosahydro-cyclopenta[a]chrysene-3a-carboxylic acid; AIDS-051817; AIDS051817; 3-Oxolup-20(29)-en-28-oic acid;Liquidambaric acid | C30H46O3 | 454.68 | CC(=C)C1CCC2(C1C3CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C(=O)O |
| TCMBANKIN058704 | lupeol | AC-1371; AKOS015960466; SCHEMBL14067725; 4CN-0933; C08628; BC201808; Lup-20(29)-en-3.beta.-ol; NSC90487; ZINC04081455; D0RA6H; Lupeol; LMPR01060013; lupeol ; Monogynol B; .beta.-Viscol; NCI60_042005; lup-20(29)-en-3beta-ol; Lupenol | C30H50O | 426.7 g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)C |
| TCMBANKIN058706 | betulin | AKOS025402304; Ambotz473-98-3; betulin ; AC-7983; SCHEMBL9888462; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol; FVWJYYTZTCVBKE-MAIYTPNSSA-N; ; Trochol; 18211-63-7; C08618; Messagenin; 473-98-3; AIDS002710; B9757_SIGMA; ZINC03978650; Prestwick3_000990; Betulin; MEGxp0_001726; AI3-62999; BSPBio_001059; Lup-20(30)-ene-3beta,28-diol; C08631; Betulinol; ACon1_000091; AIDS-002710; Lup-20(29)-ene-3beta,28-diol; BPBio1_001165; Betuline; Lup-20(29)-ene-3,28-diol, (3beta)-; NSC 4644; (3.beta.)-Lup-20(29)-ene-3,28-diol; NSC692218; EINECS 207-475-5; Betulinic alcohol; ST5411404; Trochol | C30H50O2 | 442.7g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO |
| TCMBANKIN058927 | 3-acetyl-4-hydroxybenzoic acid;Acetyl-4-hydroxy-benzoic acid | 3-ethanoyl-4-hydroxy-benzoic acid; 3-acetyl-4-hydroxy-benzoic acid | C9H8O4 | 180.16 g/mol | CC(=O)C1=C(C=CC(=C1)C(=O)O)O |
| TCMBANKIN059277 | megastigmenetetrol | (3s,5r,6r,7 e,9r)-3,5,6,9-tetrahydroxy-7-megastigmene;(3S,SR,6R,7E;9S)-megastiman-7-ene-3,5,6,9-tetrol | C13H24O4 | 244.33 g/mol | CC(C=CC1(C(CC(CC1(C)O)O)(C)C)O)O |
| TCMBANKIN059599 | taraxe-rol | C30H50O | 426.7 g/mol | CC1(CCC2(CC=C3C4(CCC5C(C(CCC5(C4CCC3(C2C1)C)C)O)(C)C)C)C)C | |
| TCMBANKIN059604 | beta-amyrenonol | C30H48O2 | 440.7 g/mol | CC1(CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C)C | |
| TCMBANKIN059746 | α-tocopherol | C29H50O2 | 430.7 g/mol | CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C | |
| TCMBANKIN059888 | eriojaposide a | C24H38O11 | 502.6 g/mol | CC1=CC(=O)CC(C1C=CC(C)OC2C(C(C(C(O2)COC3C(C(C(CO3)O)O)O)O)O)O)(C)C | |
| TCMBANKIN060140 | friedelan-3-one | C30H50O | 426.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C | |
| TCMBANKIN060534 | 23-hydroxytormentic acid | C30H48O6 | 504.7 g/mol | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1(C)O)C)C(=O)O | |
| TCMBANKIN060556 | peduneuloside | C36H58O10 | 650.84 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O | |
| TCMBANKIN060598 | 2α,3β,19α-trihydroxy-28-norurs-12-ene | C29H48O3 | CC1CCC2CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1(C)O)C | ||
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060694 | 24-Ethylcholest-4-en-3-one | C29H48O | 412.69 | CCC(CCC(C)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(C)C | |
| TCMBANKIN061148 | n-tetratriacontanol | C34H70O | 494.9 g/mol | CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO | |
| TCMBANKIN061486 | 5-hydroxy-3',4',6,7-tetramethoxyflavone | 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxychromen-4-one; 21763-80-4; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-chromone; AIDS218321; 5-Hydroxy-3',4',6,7-tetramethoxyflavone; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-chromen-4-one; 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4-chromenone; AIDS-218321; 5-Hydroxy-6,7,3',4'-tetramethoxyflavone; HTMF; 5-hydroxy-3′,4′,6,7-tetramethoxyflavone; 5-hydroxy-6,7,3',4'-tetramethoxyflavone; 5-hydroxy-6,7,3 ', 4'-tetramethoxy flavone; AC1L48C3; 57296-14-7; 3'-O-methyl-eupatorin; 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one; BDBM50092614; DTXSID50176163; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxychromen-4-one; 3,5-dihydroxy-6,7,3',4'-tetramethoxyflavone; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-chromen-4-one; 5-Hydroxy-3',4',6,7-tetramethoxyflavone; 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-chromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-; AK583634; QEWSAPKRFOFQIU-UHFFFAOYSA-N; HTMF; SCHEMBL3131502; 21763-80-4; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-; CTK4E7643; 5-hydroxy-6,7-dimethoxy-2-(3,4-dimethoxyphenyl)-4H-chromen-4-one; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-4-chromenone; CHEMBL226508; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxychromen-4-one; LMPK12111243; 2-(3,4-dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-chromone; AKOS030553584; Belamcanidin; 6-Hydroxyluteolin 6,7,3',4'-tetramethyl ether; 5-Hydroxy-6,7,3',4'-tetramethoxyflavone; 4H-1-Benzopyran-4-one,2-(3,4-dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-; 2-(3,4-Dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-4H-1-benzopyran-4-one; 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-chromen-4-one #; 5-demethylsinensetin; belamcanidin; 3,5-Dihydroxy-6,7,3',4'-tetramethoxyflavone; belamcadin | C19H18O7 | 358.3 g/mol | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab